Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekAJMC ↗
Paul Richardson, MD, Calls Mezigdomide "CAR T in a Pill" for Patients With R/R Multiple Myeloma…
The WeekFiercePharma ↗
The accelerated approval for Jazz Pharmaceuticals' small cell lung cancer drug Zepzelca may once again be in j…
The WeekFierceBiotech ↗
Over-the-counter drugmaker Perrigo Company is washing its hands of chief executive Patrick Lockwood-Taylor, wh…
The WeekBriefing
Belgium, the Netherlands, Luxembourg, Austria, and Ireland jointly called for EU-level coordination on pharmac…
The WeekBriefing
Federal efforts to stabilize stand-alone drug plan premiums are dwarfed by Medicare Advantage rebate flows exc…
The WeekFiercePharma ↗
An independent research firm is reviewing data on Amgen's Tavneos as the company prepares for a hearing with t…
The WeekFierceBiotech ↗
Boehringer Ingelheim's Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared …
The WeekBriefing
The Trump administration proposed changes aimed at closing a loophole in Medicare’s drug price negotiation fra…
The WeekFiercePharma ↗
The Trump administration is floating a proposal to establish a permanent framework for the Medicare drug price…
The WeekFierceBiotech ↗
Christelle Huguet, Ph.D., Ipsen's executive vice president and head of R&D, sits down with Fierce Healthca…
The WeekBriefing
Blood Cancer United is purchasing leftover supplies of an investigational cancer therapy to keep access open a…
The WeekBriefing
The agency’s approval resolves a prior dispute within CDER and expands Tzield’s reach in autoimmune diabetes.…
The WeekAJMC ↗
Specialty Pharmacy Drives Advanced Therapy Access: Fran Gregory, PharmD…
The WeekAJMC ↗
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology…
The WeekAJMC ↗
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD…
The WeekAJMC ↗
SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD…
The WeekSTAT News ↗
The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DR…
The WeekFiercePharma ↗
J&J's MonumenTAL-3 phase 3 study of bispecific antibody Talvey and Darzalex Faspro in patients with earlie…
The WeekFierceBiotech ↗
Elon Musk's SpaceX may be igniting global headlines with the company's astronomical IPO, but biotech listings …
The WeekBriefing
Prometheus secured $12 billion to build its “artificial engineers,” part of a week of biotech activity spannin…
The WeekAJMC ↗
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD…
The WeekSTAT News ↗
"There are some physicians that work to 100": Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.…
The WeekSTAT News ↗
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmace…
The WeekBioPharma Dive ↗
In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company i…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.